World’s first female spacewalking team makes history

US astronauts Jessica Meir, left, and Christina Koch pose for a photo in the International Space Station. (NASA via AP)
Updated 18 October 2019

World’s first female spacewalking team makes history

  • NASA astronauts Christina Koch and Jessica Meir exited the International Space Station on Friday

CAPE CANAVERAL, Florida: The world’s first female spacewalking team is making history high above Earth.
NASA astronauts Christina Koch and Jessica Meir exited the International Space Station on Friday, the first time in a half-century of spacewalking that a woman floated out without a male crewmate. Their job is to fix a broken part of the station’s solar power network.
America’s first female spacewalker from 35 years ago, Kathy Sullivan, is delighted. She says it’s good to finally have enough women in the astronaut corps and trained for spacewalking for this to happen.

NASA originally wanted to conduct an all-female spacewalk last spring, but did not have enough medium-size suits ready to go.

When a Saudi went to space
Prince Sultan bin Salman speaks exclusively to Arab News about his 1985 NASA mission and how he became the first Arab, Muslim and royal in space

Enter


keywords

 


GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

Updated 28 May 2020

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

  • British drugmaker in talks with governments on backing for the program
  • Experts have predicted that a successful vaccine will take over a year to develop

GlaxoSmithKline will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.
The London-listed company said it was in talks with governments on backing for the program, which would effectively allow for a scaling up of production of future successful vaccines for the disease caused by the novel coronavirus.
GSK is one of several companies in the race to develop a vaccine for the respiratory illness that currently has no treatment and has already killed about 350,000 people.
The British drugmaker is working on its own COVID vaccine with Sanofi.
Adjuvants have been shown to create a stronger and longer-lasting immunity against infections.
GSK’s adjuvant can reduce the amount of vaccine protein required per dose, which would allow for more vaccines to be made, the British drugmaker said.
Experts have predicted that a successful vaccine will take over a year to develop, and companies and governments are pouring money into dozens of programs as the only viable solution that will allow the world to escape durably from coronavirus lockdowns and get economies moving again.